Patients should never discontinue tirzepatide without consulting their healthcare provider, as abrupt cessation may lead to deterioration in glycemic control or weight management
Safety and Tolerability (10%) : Formulations must be suitable for sensitive skin and tested to ensure they do not cause irritation, especially in melanin-rich skin prone to post-inflammatory changes
I know I was harsh in my opening paragraph about not doing dose titration but the drug does work
Common adverse effects (percent incidence) Serious risks include pancreatitis, gallbladder issues, and thyroid C-cell tumors (boxed warning for both)
Individual results varied significantly, with some participants losing over 20 percent and others losing less than 10 percent
NOTE TO PHARMACY CUSTOMERS: Notwithstanding the disclosures in this Policy, all pharmacy activities that involve Protected Health Information (PHI) as defined under the Health Insurance Portability & Accountability Act and related laws and regulations (collectively referred to as HIPAA) are subject to our posted HIPAA Notice of Privacy Practices